Summit Therapeutics Inc. (SMMT) Operating margin 2017–2022
Summit Therapeutics Inc. (SMMT) operating margin by fiscal year — reported operating income divided by reported revenue.
-10225.4%FY2022 · since FY2017: -176.1% → -10225.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -10225.4% | -5461.1 pp |
| FY2021 | -4764.3% | +1420.9 pp |
| FY2020 | -6185.2% | — |
| FY2018 | 9.4% | +185.6 pp |
| FY2017 | -176.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice